Ariceum Therapeutics, a Berlin-based private biotech company, has announced a significant regulatory milestone, with the US Food and Drug...
Read MoreQureight Ltd and Avalyn Pharma Inc. have announced a strategic partnership to advance research in progressive pulmonary fibrosis (PPF),...
Read MoreIn a significant advancement for Alzheimer’s treatment, the U.S. Food and Drug Administration (FDA) has approved Eisai and Biogen’s...
Read MoreOn 24 January 2025, the Medicines and Healthcare products Regulatory Agency (MHRA) approved garadacimab, marketed under the brand name...
Read MoreIn a groundbreaking development for medical science, the INTERCEPT project has launched Europe’s first biomarker trial aimed at preventing...
Read MoreTris Pharma, Inc. has announced highly encouraging results from its ALLEVIATE-1 phase 3 clinical trial evaluating cebranopadol as a...
Read More